Nano4 awarded with P2020 Grant


Nano4 Global was awarded with a P2020 Grant for the scale-up of CoVID-19 Diagnostic System. This Grant will be instrumental for scale-up of a Diagnostic System for the molecular diagnostic of SARS-CoV-2.
Nano4 Global is a company, spin-off from FCT-Nova, established in 2015 and specialised on the development of Molecular Diagnostic Systems.
P2020 was set to bring together the five European Structural and Investment Funds - ERDF, Cohesion Fund, ESF, EAFRD and EMFF – setting the programming principles which enshrine the economic, social and territorial development policy to be advanced in Portugal, between 2014 and 2020.


News & Updates
  August  2022
-Nano4 Global is one of the 15 Biotech companies in Portugal that you should know
  July  2021
NANO4 in partnership with CUF Hospitals and Clinics network initiates validation of diagnostics platform for Chronic Myeloid Leukaemia